Vitexin: A Dietary Flavonoid with Potential Protective Effects Against Liver Diseases

References

• Cheng, M. L.; Nakib, D.; Perciani, C. T.; MacParland, S. A. The Immune Niche of the Liver. Clin Sci. (Lond). 2021, 135(20), 2445–2466. DOI: 10.1042/cs20190654.
   PubMed Web of Science ®Google Scholar
• Xiao, J.; Wang, F.; Wong, N. K.; He, J.; Zhang, R.; Sun, R.; Xu, Y.; Liu, Y.; Li, W.; Koike, K., et al. Global Liver Disease Burdens and Research Trends: Analysis from a Chinese Perspective. J. Hepatol. 2019, 71 (1), 212–221. DOI: 10.1016/j.jhep.2019.03.004.
   PubMed Web of Science ®Google Scholar
• Asrani, S. K.; Devarbhavi, H.; Eaton, J.; Kamath, P. S. Burden of Liver Diseases in the World. J. Hepatol. 2019, 70(1), 151–171. DOI: 10.1016/j.jhep.2018.09.014.
   PubMed Web of Science ®Google Scholar
• Neshat, S. Y.; Quiroz, V. M.; Wang, Y.; Tamayo, S.; Doloff, J. C. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions. Int. J. Mol. Sci. 2021, 22(13), 6777. DOI: 10.3390/ijms22136777.
   PubMed Web of Science ®Google Scholar
• Ye, Y.; Zhou, J. The Protective Activity of Natural Flavonoids Against Osteoarthritis by Targeting NF-Κb Signaling Pathway. Front. Endocrinol. (Lausanne). 2023, 14, 1117489. DOI: 10.3389/fendo.2023.1117489.
   PubMed Web of Science ®Google Scholar
• Darband, S. G.; Kaviani, M.; Yousefi, B.; Sadighparvar, S.; Pakdel, F. G.; Attari, J. A.; Mohebbi, I.; Naderi, S.; Majidinia, M. Quercetin: A Functional Dietary Flavonoid with Potential Chemo-Preventive Properties in Colorectal Cancer. J. Cell. Physiol. 2018, 233(9), 6544–6560. DOI: 10.1002/jcp.26595.
   PubMed Web of Science ®Google Scholar
• Badshah, S. L.; Faisal, S.; Muhammad, A.; Poulson, B. G.; Emwas, A. H.; Jaremko, M. Antiviral Activities of Flavonoids. Biomed. Pharmacother. 2021, 140, 111596. DOI: 10.1016/j.biopha.2021.111596.
   PubMed Web of Science ®Google Scholar
• Tan, Z.; Deng, J.; Ye, Q.; Zhang, Z. The Antibacterial Activity of Natural-Derived Flavonoids. Curr. Top. Med. Chem. 2022, 22(12), 1009–1019. DOI: 10.2174/1568026622666220221110506.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Schuppan, D. Traditional Chinese Medicine (TCM) for Fibrotic Liver Disease: Hope and Hype. J. Hepatol. 2014, 61(1), 166–168. DOI: 10.1016/j.jhep.2014.03.009.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Wang, S.; Kan, J.; Zhang, J.; Zhou, L.; Huang, Y.; Zhang, Y. Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling. Curr. Neuropharmacol. 2020, 18(4), 260–276. DOI: 10.2174/1570159x17666191101125530.
   PubMed Web of Science ®Google Scholar
• Hao, P.; Jiang, F.; Cheng, J.; Ma, L.; Zhang, Y.; Zhao, Y. Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms. J. Am. Coll. Cardiol. 2017, 69(24), 2952–2966. DOI: 10.1016/j.jacc.2017.04.041.
   PubMed Web of Science ®Google Scholar
• Meng, J.; Zhu, Y.; Ma, H.; Wang, X.; Zhao, Q. The Role of Traditional Chinese Medicine in the Treatment of Cognitive Dysfunction in Type 2 Diabetes. J. Ethnopharmacol. 2021, 280, 114464. DOI: 10.1016/j.jep.2021.114464.
   PubMed Web of Science ®Google Scholar
• He, J. D.; Wang, Z.; Li, S. P.; Xu, Y. J.; Yu, Y.; Ding, Y. J.; Yu, W. L.; Zhang, R. X.; Zhang, H. M.; Du, H. Y. Vitexin Suppresses Autophagy to Induce Apoptosis in Hepatocellular Carcinoma via Activation of the JNK Signaling Pathway. Oncotarget. 2016, 7(51), 84520–84532. DOI: 10.18632/oncotarget.11731.
   PubMedGoogle Scholar
• Lund, J. A.; Brown, P. N.; Shipley, P. R. Quantification of North American and European Crataegus Flavonoids by Nuclear Magnetic Resonance Spectrometry. Fitoterapia. 2020, 143, 104537. DOI: 10.1016/j.fitote.2020.104537.
   PubMed Web of Science ®Google Scholar
• Yao, Y.; Cheng, X. Z.; Wang, L. X.; Wang, S. H.; Ren, G. Major Phenolic Compounds, Antioxidant Capacity and Antidiabetic Potential of Rice Bean (Vigna Umbellata L.) in China. Int. J. Mol. Sci. 2012, 13(3), 2707–2716. DOI: 10.3390/ijms13032707.
   PubMed Web of Science ®Google Scholar
• Kim, G. H.; Lim, K.; Yang, H. S.; Lee, J. K.; Kim, Y.; Park, S. K.; Kim, S. H.; Park, S.; Kim, T. H.; Moon, J. S., et al. Improvement in Neurogenesis and Memory Function by Administration of Passiflora Incarnata L. Extract Applied to Sleep Disorder in Rodent Models. J. Chem. Neuroanat. 2019. 98, 27–40. DOI: 10.1016/j.jchemneu.2019.03.005.
   PubMed Web of Science ®Google Scholar
• Gaitan, E.; Lindsay, R. H.; Reichert, R. D.; Ingbar, S. H.; Cooksey, R. C.; Legan, J.; Meydrech, E. F.; Hill, J.; Kubota, K. Antithyroid and Goitrogenic Effects of Millet: Role of C-Glycosylflavones. J. Clin. Endocrinol. Metab. 1989, 68(4), 707–714. DOI: 10.1210/jcem-68-4-707.
   PubMed Web of Science ®Google Scholar
• Moheb, A.; Ibrahim, R. K.; Roy, R.; Sarhan, F. Changes in Wheat Leaf Phenolome in Response to Cold Acclimation. Phytochemistry. 2011, 72(18), 2294–2307. DOI: 10.1016/j.phytochem.2011.08.021.
   PubMed Web of Science ®Google Scholar
• Li, S.; Liang, T.; Zhang, Y.; Huang, K.; Yang, S.; Lv, H.; Chen, Y.; Zhang, C.; Guan, X. Vitexin Alleviates High-Fat Diet Induced Brain Oxidative Stress and Inflammation via Anti-Oxidant, Anti-Inflammatory and Gut Microbiota Modulating Properties. Free Radic Biol Med. 2021, 171, 332–344. DOI: 10.1016/j.freeradbiomed.2021.05.028.
   PubMed Web of Science ®Google Scholar
• Liu, X.; Jiang, Q.; Liu, H.; Luo, S. Vitexin Induces Apoptosis Through Mitochondrial Pathway and PI3K/Akt/mTOR Signaling in Human Non-Small Cell Lung Cancer A549 Cells. Biol. Res. 2019, 52(1), 7. DOI: 10.1186/s40659-019-0214-y.
   PubMedGoogle Scholar
• Król-Kogus, B.; Głód, D.; Hałasa, R.; Krauze-Baranowska, M.; Pobłocka-Olech, L. 2D LC As a Tool for Standardization of Foenugraeci Semen Extracts Containing Compounds with Anti-Helicobacter pylori Activity. Food Funct. 2021, 12(6), 2686–2692. DOI: 10.1039/d1fo00226k.
   PubMed Web of Science ®Google Scholar
• Ninfali, P.; Antonelli, A.; Magnani, M.; Scarpa, E. S. Antiviral Properties of Flavonoids and Delivery Strategies. Nutrients. 2020, 12(9), 2534. DOI: 10.3390/nu12092534.
   PubMed Web of Science ®Google Scholar
• Xue, W.; Wang, X.; Tang, H.; Sun, F.; Zhu, H.; Huang, D.; Dong, L. Vitexin Attenuates Myocardial Ischemia/Reperfusion Injury in Rats by Regulating Mitochondrial Dysfunction Induced by Mitochondrial Dynamics Imbalance. Biomed. Pharmacother. 2020, 124, 109849. DOI: 10.1016/j.biopha.2020.109849.
   PubMed Web of Science ®Google Scholar
• Noor, K. K.; Ijaz, M. U.; Ehsan, N.; Tahir, A.; Yeni, D. K.; Neamul Kabir Zihad, S. M.; Uddin, S. J.; Ashraf, A.; Simal-Gandara, J. Hepatoprotective Role of Vitexin Against Cadmium-Induced Liver Damage in Male Rats: A Biochemical, Inflammatory, Apoptotic and Histopathological Investigation. Biomed. Pharmacother. 2022, 150, 112934. DOI: 10.1016/j.biopha.2022.112934.
   PubMed Web of Science ®Google Scholar
• Li, C.; Chen, Y.; Yuan, X.; He, L.; Li, X.; Huang, S.; Hou, S.; Liang, J. Vitexin Ameliorates Chronic Stress Plub High Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Inhibiting Inflammation. Eur. J. Pharmacol. 2020, 882, 173264. DOI: 10.1016/j.ejphar.2020.173264.
   PubMed Web of Science ®Google Scholar
• Hamza, A. A.; Lashin, F. M.; Gamel, M.; Hassanin, S. O.; Abdalla, Y.; Amin, A. Hawthorn Herbal Preparation from Crataegus Oxyacantha Attenuates in vivo Carbon Tetrachloride -Induced Hepatic Fibrosis via Modulating Oxidative Stress and Inflammation. Antioxidants (Basel). 2020, 9(12), 1173. DOI: 10.3390/antiox9121173.
   PubMedGoogle Scholar
• Lee, J. H.; Mohan, C. D.; Shanmugam, M. K.; Rangappa, S.; Sethi, G.; Siveen, K. S.; Chinnathambi, A.; Alahmadi, T. A.; Alharbi, S. A.; Basappa, S., et al. Vitexin Abrogates Invasion and Survival of Hepatocellular Carcinoma Cells Through Targeting STAT3 Signaling Pathway. Biochimie. 2020. 175, 58–68. DOI: 10.1016/j.biochi.2020.05.006.
   PubMed Web of Science ®Google Scholar
• He, M.; Min, J. W.; Kong, W. L.; He, X. H.; Li, J. X.; Peng, B. W. A Review on the Pharmacological Effects of Vitexin and Isovitexin. Fitoterapia. 2016, 115, 74–85. DOI: 10.1016/j.fitote.2016.09.011.
   PubMed Web of Science ®Google Scholar
• Che Zain, M. S.; Osman, M. F.; Lee, S. Y.; Shaari, K. UHPLC-UV/PDA Method Validation for Simultaneous Quantification of Luteolin and Apigenin Derivatives from Elaeis Guineensis Leaf Extracts: An Application for Antioxidant Herbal Preparation. Molecules. 2021, 26(4), 1084. DOI: 10.3390/molecules26041084.
   PubMed Web of Science ®Google Scholar
• Babaei, F.; Moafizad, A.; Darvishvand, Z.; Mirzababaei, M.; Hosseinzadeh, H.; Nassiri-Asl, M. Review of the Effects of Vitexin in Oxidative Stress-Related Diseases. Food Sci. Nutr. 2020, 8(6), 2569–2580. DOI: 10.1002/fsn3.1567.
   PubMed Web of Science ®Google Scholar
• Praveena, R.; Sadasivam, K.; Kumaresan, R.; Deepha, V.; Sivakumar, R. Experimental and DFT Studies on the Antioxidant Activity of a C-Glycoside from Rhynchosia Capitata. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2013, 103, 442–452. DOI: 10.1016/j.saa.2012.11.001.
   PubMed Web of Science ®Google Scholar
• Luo, J.; Cai, W.; Wu, T.; Xu, B. Phytochemical Distribution in Hull and Cotyledon of Adzuki Bean (Vigna Angularis L.) and Mung Bean (Vigna Radiate L.), and Their Contribution to Antioxidant, Anti-Inflammatory and Anti-Diabetic Activities. Food Chem. 2016, 201, 350–360. DOI: 10.1016/j.foodchem.2016.01.101.
   PubMed Web of Science ®Google Scholar
• Bai, Y.; Chang, J.; Xu, Y.; Cheng, D.; Liu, H.; Zhao, Y.; Yu, Z. Antioxidant and Myocardial Preservation Activities of Natural Phytochemicals from Mung Bean (Vigna Radiata L.) Seeds. J. Agric. Food. Chem. 2016, 64(22), 4648–4655. DOI: 10.1021/acs.jafc.6b01538.
   PubMed Web of Science ®Google Scholar
• Yao, Y.; Cheng, X.; Wang, L.; Wang, S.; Ren, G. A Determination of Potential α-Glucosidase Inhibitors from Azuki Beans (Vigna Angularis). Int. J. Mol. Sci. 2011, 12(10), 6445–6451. DOI: 10.3390/ijms12106445.
   PubMed Web of Science ®Google Scholar
• Xiaofang, P.; Zheng, Z.; Kawing, C.; Shan, F.; Ren, G.-X.; Chen, F.; Wang, M. Inhibitory Effect of Mung Bean Extract and Its Constituents Vitexin and Isovitexin on the Formation of Advanced Glycation Endproducts. Food Chem. 2008, 106(2), 475–481. DOI: 10.1016/j.foodchem.2007.06.016.
   Web of Science ®Google Scholar
• Zucolotto, S. M.; Fagundes, C.; Reginatto, F. H.; Ramos, F. A.; Castellanos, L.; Duque, C.; Schenkel, E. P. Analysis of C-Glycosyl Flavonoids from South American Passiflora Species by HPLC-DAD and HPLC-MS. Phytochem. Anal. 2012, 23(3), 232–239. DOI: 10.1002/pca.1348.
   PubMed Web of Science ®Google Scholar
• Bedell, S.; Wells, J.; Liu, Q.; Breivogel, C. Vitexin As an Active Ingredient in Passion Flower with Potential As an Agent for Nicotine Cessation: Vitexin Antagonism of the Expression of Nicotine Locomotor Sensitization in Rats. Pharm. Biol. 2019, 57(1), 8–12. DOI: 10.1080/13880209.2018.1561725.
   PubMed Web of Science ®Google Scholar
• Alves, J. S. F.; Silva, A.; da Silva, R. M.; Tiago, P. R. F.; de Carvalho, T. G.; de Araújo Júnior, R. F.; de Azevedo, E. P.; Lopes, N. P.; Ferreira, L. S.; Gavioli, E. C., et al. In vivo Antidepressant Effect of Passiflora Edulis F. Flavicarpa into Cationic Nanoparticles: Improving Bioactivity and Safety. Pharmaceutics. 2020, 12(4), 383.
   PubMed Web of Science ®Google Scholar
• Anzoise, M. L.; Marrassini, C.; Bach, H.; Gorzalczany, S. Beneficial Properties of Passiflora Caerulea on Experimental Colitis. J. Ethnopharmacol. 2016, 194, 137–145. DOI: 10.1016/j.jep.2016.09.002.
   PubMed Web of Science ®Google Scholar
• de Oliveira, P. T. F.; Dos Santos, E. L.; da Silva, W. A. V.; Ferreira, M. R. A.; Soares, L. A. L.; da Silva, F. A.; da Silva, F. S. B. Production of Biomolecules of Interest to the Anxiolytic Herbal Medicine Industry in Yellow Passionfruit Leaves (Passiflora Edulis F. Flavicarpa) Promoted by Mycorrhizal Inoculation. J. Sci. Food Agric. 2019, 99(7), 3716–3720. DOI: 10.1002/jsfa.9598.
   PubMed Web of Science ®Google Scholar
• Colomeu, T. C.; de Figueiredo, D.; de Matos da Silva, P.; Fernandes, L. G. R.; Zollner, R. L. Antiproliferative and Pro-Oxidant Effect of Polyphenols in Aqueous Leaf Extract of Passiflora Alata Curtis on Activated T Lymphocytes from Non-Obese Diabetic (NOD SHILT/J) Mice. Antioxidants (Basel). 2022, 11(8), 1503. DOI: 10.3390/antiox11081503.
   PubMedGoogle Scholar
• Colomeu, T. C.; Figueiredo, D.; Cazarin, C. B.; Schumacher, N. S.; Maróstica, M. R., Jr.; Meletti, L. M.; Zollner, R. L. Antioxidant and Anti-Diabetic Potential of Passiflora Alata Curtis Aqueous Leaves Extract in Type 1 Diabetes Mellitus (NOD-Mice). Int. Immunopharmacol. 2014, 18(1), 106–115. DOI: 10.1016/j.intimp.2013.11.005.
   PubMed Web of Science ®Google Scholar
• Vargas, A. J.; Geremias, D. S.; Provensi, G.; Fornari, P. E.; Reginatto, F. H.; Gosmann, G.; Schenkel, E. P.; Fröde, T. S. Passiflora Alata and Passiflora Edulis Spray-Dried Aqueous Extracts Inhibit Inflammation in Mouse Model of Pleurisy. Fitoterapia. 2007, 78(2), 112–119. DOI: 10.1016/j.fitote.2006.09.030.
   PubMed Web of Science ®Google Scholar
• da Silva Morrone, M.; de Assis, A. M.; da Rocha, R. F.; Gasparotto, J.; Gazola, A. C.; Costa, G. M.; Zucolotto, S. M.; Castellanos, L. H.; Ramos, F. A.; Schenkel, E. P., et al. Passiflora Manicata (Juss.) Aqueous Leaf Extract Protects Against Reactive Oxygen Species and Protein Glycation in vitro and ex vivo Models. Food. Chem. Toxicol. 2013, 60, 45–51. DOI: 10.1016/j.fct.2013.07.028.
   PubMed Web of Science ®Google Scholar
• Nassiri-Asl, M.; Shariati-Rad, S.; Zamansoltani, F. Anticonvulsant Effects of Aerial Parts of Passiflora Incarnata Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors. BMC Complement. Altern. Med. 2007, 7(1), 26. DOI: 10.1186/1472-6882-7-26.
   PubMedGoogle Scholar
• Gomes, S. V. F.; Portugal, L. A.; dos Anjos, J. P.; de Jesus, O. N.; de Oliveira, E. J.; David, J. P.; David, J. M. Accelerated Solvent Extraction of Phenolic Compounds Exploiting a Box-Behnken Design and Quantification of Five Flavonoids by HPLC-DAD in Passiflora Species. Microchem. J. 2017, 132, 28–35. DOI: 10.1016/j.microc.2016.12.021.
   Web of Science ®Google Scholar
• Gu, C. B.; Ma, H.; Ning, W. J.; Niu, L. L.; Han, H. Y.; Yuan, X. H.; Fu, Y. J. Characterization, Culture Medium Optimization and Antioxidant Activity of an Endophytic Vitexin-Producing Fungus Dichotomopilus Funicola Y3 from Pigeon Pea [Cajanus Cajan (L.) Millsp.]. J. Appl. Microbiol. 2018, 125(4), 1054–1065. DOI: 10.1111/jam.13928.
   PubMed Web of Science ®Google Scholar
• Wei, Z. F.; Jin, S.; Luo, M.; Pan, Y. Z.; Li, T. T.; Qi, X. L.; Efferth, T.; Fu, Y. J.; Zu, Y. G. Variation in Contents of Main Active Components and Antioxidant Activity in Leaves of Different Pigeon Pea Cultivars During Growth. J. Agric. Food. Chem. 2013, 61(42), 10002–10009. DOI: 10.1021/jf402455m.
   PubMed Web of Science ®Google Scholar
• Ni, Q.; Xu, G.; Wang, Z.; Gao, Q.; Wang, S.; Zhang, Y. Seasonal Variations of the Antioxidant Composition in Ground Bamboo Sasa Argenteastriatus Leaves. Int. J. Mol. Sci. 2012, 13(2), 2249–2262. DOI: 10.3390/ijms13022249.
   PubMed Web of Science ®Google Scholar
• Shu, G.; Kong, F.; Xu, D.; Yin, L.; He, C.; Lin, J.; Fu, H.; Wang, K.; Tian, Y.; Zhao, X. Bamboo Leaf Flavone Changed the Community of Cecum Microbiota and Improved the Immune Function in Broilers. Sci. Rep. 2020, 10(1), 12324. DOI: 10.1038/s41598-020-69010-1.
   PubMed Web of Science ®Google Scholar
• Yang, J. H.; Choi, M. H.; Yang, S. H.; Cho, S. S.; Park, S. J.; Shin, H. J.; Ki, S. H. Potent Anti-Inflammatory and Antiadipogenic Properties of Bamboo (Sasa Coreana Nakai) Leaves Extract and Its Major Constituent Flavonoids. J. Agric. Food. Chem. 2017, 65(31), 6665–6673. DOI: 10.1021/acs.jafc.7b02203.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Chen, B.; Cao, H. Y.; Li, J. E.; Chen, L. L.; Zhang, Q. F. Pancreatic Lipase Inhibitory Activity of Bambusa Multiplex Cv. Fernleaf Leaf Extract in vitro and in vivo. Food Funct. 2021, 12(16), 7440–7447. DOI: 10.1039/d1fo01168e.
   PubMed Web of Science ®Google Scholar
• Cao, G.; Yu, Y.; Wang, H.; Liu, J.; Zhang, X.; Yu, Y.; Li, Z.; Zhang, Y.; Yang, C. Effects of Oral Administration of Bamboo (Dendrocalamus Membranaceus) Leaf Flavonoids on the Antioxidant Capacity, Caecal Microbiota, and Serum Metabolome of Gallus Gallus Domesticus. Front Nutr. 2022, 9, 848532. DOI: 10.3389/fnut.2022.848532.
   PubMed Web of Science ®Google Scholar
• Yang, J. P.; He, H.; Lu, Y. H. Four Flavonoid Compounds from Phyllostachys Edulis Leaf Extract Retard the Digestion of Starch and Its Working Mechanisms. J. Agric. Food. Chem. 2014, 62(31), 7760–7770. DOI: 10.1021/jf501931m.
   PubMed Web of Science ®Google Scholar
• Gaitan, E.; Cooksey, R. C.; Legan, J.; Lindsay, R. H. Antithyroid Effects in vivo and in vitro of Vitexin: A C-Glucosylflavone in Millet. J. Clin. Endocrinol. Metab. 1995, 80(4), 1144–1147. DOI: 10.1210/jcem.80.4.7714083.
   PubMed Web of Science ®Google Scholar
• Zhang, J.; Yuan, K.; Zhou, W. L.; Zhou, J.; Yang, P. Studies on the Active Components and Antioxidant Activities of the Extracts of Mimosa Pudica Linn. from Southern China. Pharmacogn. Mag. 2011, 7(25), 35–39. DOI: 10.4103/0973-1296.75899.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Ma, X. M.; Wang, X. C.; Liu, J. H.; Huang, B. Y.; Guo, X. Y.; Xiong, S. P.; La, G. X. UPLC-QTOF Analysis Reveals Metabolomic Changes in the Flag Leaf of Wheat (Triticum Aestivum L.) Under Low-Nitrogen Stress. Plant Physiol. Biochem. 2017, 111, 30–38. DOI: 10.1016/j.plaphy.2016.11.009.
   PubMed Web of Science ®Google Scholar
• Costa, E. C.; Menezes, P. M. N.; Silva, F. S.; Ribeiro, L. A. A.; Rolim, L. A.; Araújo, E.; Nunes, X. P. Jatropha Mutabilis, a New Source of Vitexin: HPLC Quantification and Pharmacological Evaluation. Nat. Prod. Res. 2021, 35(24), 6200–6203. DOI: 10.1080/14786419.2020.1837807.
   PubMed Web of Science ®Google Scholar
• Lee, J. H.; Lee, S.; Nguyen, Q. N.; Phung, H. M.; Shin, M. S.; Kim, J. Y.; Choi, H.; Shim, S. H.; Kang, K. S. Identification of the Active Ingredient and Beneficial Effects of Vitex Rotundifolia Fruits on Menopausal Symptoms in Ovariectomized Rats. Biomolecules. 2021, 11(7), 1033. DOI: 10.3390/biom11071033.
   PubMed Web of Science ®Google Scholar
• Sarkar, M. K.; Kar, A.; Jayaraman, A.; Kar Mahapatra, S.; Vadivel, V. Vitexin Isolated from Prosopis Cineraria Leaves Induce Apoptosis in K-562 Leukemia Cells via Inhibition of the BCR-ABL-Ras-Raf Pathway. J. Pharm. Pharmacol. 2022, 74(1), 103–111. DOI: 10.1093/jpp/rgab085.
   PubMed Web of Science ®Google Scholar
• Malar, D. S.; Prasanth, M. I.; Shafreen, R. B.; Balamurugan, K.; Devi, K. P. Grewia Tiliaefolia and Its Active Compound Vitexin Regulate the Expression of Glutamate Transporters and Protect Neuro-2a Cells from Glutamate Toxicity. Life. sci. 2018, 203, 233–241. DOI: 10.1016/j.lfs.2018.04.047.
   PubMed Web of Science ®Google Scholar
• Sheeja Malar, D.; Beema Shafreen, R.; Karutha Pandian, S.; Pandima Devi, K. Cholinesterase Inhibitory, Anti-Amyloidogenic and Neuroprotective Effect of the Medicinal Plant Grewia Tiliaefolia - an in vitro and in silico Study. Pharm. Biol. 2017, 55(1), 381–393. DOI: 10.1080/13880209.2016.1241811.
   PubMed Web of Science ®Google Scholar
• Sae-Tan, S.; Kumrungsee, T.; Yanaka, N. Mungbean Seed Coat Water Extract Inhibits Inflammation in LPS-Induced Acute Liver Injury Mice and LPS-Stimulated RAW 246.7 Macrophages via the Inhibition of Tak1/iκbα/nf-Κb. J. Food Sci. Technol. 2020, 57(7), 2659–2668. DOI: 10.1007/s13197-020-04302-y.
   PubMed Web of Science ®Google Scholar
• Hwang, J. W.; Yao, H.; Caito, S.; Sundar, I. K.; Rahman, I. Redox Regulation of SIRT1 in Inflammation and Cellular Senescence. Free Radic Biol Med. 2013, 61, 95–110. DOI: 10.1016/j.freeradbiomed.2013.03.015.
   PubMed Web of Science ®Google Scholar
• Wu, H.; Zhang, G.; Huang, L.; Pang, H.; Zhang, N.; Chen, Y.; Wang, G. Hepatoprotective Effect of Polyphenol-Enriched Fraction from Folium Microcos on Oxidative Stress and Apoptosis in Acetaminophen-Induced Liver Injury in Mice. Oxid. Med. Cell Longev. 2017, 2017, 3631565. DOI: 10.1155/2017/3631565.
   PubMed Web of Science ®Google Scholar
• Fursule, R. A.; Patil, S. D. Hepatoprotective and Antioxidant Activity of Phaseolus Trilobus, Ait on Bile Duct Ligation Induced Liver Fibrosis in Rats. J. Ethnopharmacol. 2010, 129(3), 416–419. DOI: 10.1016/j.jep.2010.04.021.
   PubMed Web of Science ®Google Scholar
• Inamdar, S.; Joshi, A.; Malik, S.; Boppana, R.; Ghaskadbi, S. Vitexin Alleviates Non-Alcoholic Fatty Liver Disease by Activating AMPK in High Fat Diet Fed Mice. Biochem. Biophys. Res. Commun. 2019, 519(1), 106–112. DOI: 10.1016/j.bbrc.2019.08.139.
   PubMed Web of Science ®Google Scholar
• Hussain, A.; Cho, J. S.; Kim, J. S.; Lee, Y. I. Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice. Molecules. 2021, 26(2), 302. DOI: 10.3390/molecules26020302.
   PubMed Web of Science ®Google Scholar
• Seyedan, A.; Mohamed, Z.; Alshagga, M. A.; Koosha, S.; Alshawsh, M. A. Cynometra Cauliflora Linn. Attenuates Metabolic Abnormalities in High-Fat Diet-Induced Obese Mice. J. Ethnopharmacol. 2019, 236, 173–182. DOI: 10.1016/j.jep.2019.03.001.
   PubMed Web of Science ®Google Scholar
• Yu, Y.; Li, Z.; Cao, G.; Huang, S.; Yang, H. Bamboo Leaf Flavonoids Extracts Alleviate Oxidative Stress in HepG2 Cells via Naturally Modulating Reactive Oxygen Species Production and Nrf2-Mediated Antioxidant Defense Responses. J. Food Sci. 2019, 84(6), 1609–1620. DOI: 10.1111/1750-3841.14609.
   PubMed Web of Science ®Google Scholar
• Jiang, Y.; Gong, Q.; Gong, Y.; Zhuo, C.; Huang, J.; Tang, Q. Vitexin Attenuates Non-Alcoholic Fatty Liver Disease Lipid Accumulation in High Fat-Diet Fed Mice by Activating Autophagy and Reducing Endoplasmic Reticulum Stress in Liver. Biol. Pharm. Bull. 2022, 45(3), 260–267. DOI: 10.1248/bpb.b21-00716.
   PubMed Web of Science ®Google Scholar
• Gu, W. J.; Wang, R. Q.; Cai, Z. W.; Lin, X. J.; Zhang, L.; Chen, R. C.; Li, R.; Zhang, W. H.; Ji, X. M.; Shui, G. H., et al. Hawthorn Total Flavonoids Ameliorate Ambient Fine Particulate Matter-Induced Insulin Resistance and Metabolic Abnormalities of Lipids in Mice. Ecotoxicol. Environ. Saf. 2023, 249, 249. DOI: 10.1016/j.ecoenv.2022.114456.
   Web of Science ®Google Scholar
• Yuan, H.; Duan, S.; Guan, T.; Yuan, X.; Lin, J.; Hou, S.; Lai, X.; Huang, S.; Du, X.; Chen, S. Vitexin Protects Against Ethanol-Induced Liver Injury Through Sirt1/p53 Signaling Pathway. Eur. J. Pharmacol. 2020, 873, 173007. DOI: 10.1016/j.ejphar.2020.173007.
   PubMed Web of Science ®Google Scholar
• Ding, C.; Shen, H.; Tian, Z.; Kang, M.; Ma, J.; He, Q.; Wang, J.; Zhang, Y.; Deng, Y.; Wang, D. Protective Effect of Hawthorn Vitexin on the Ethanol-Injured DNA of BRL-3A Hepatocytes. Medicine. 2021, 100(50), e28228. DOI: 10.1097/md.0000000000028228.
   PubMed Web of Science ®Google Scholar
• Liu, X. N.; Zhao, Y. L.; Gao, E. Z.; Liu, T.; Yu, X. H.; Yu, Z. G. 绿豆黄酮对小鼠急性酒精性肝损伤的干预作用. J. Shenyang Pharmaceutical Univ. 2015, 32(1), 55–58.
   Google Scholar
• Liu, T.; Yu, X. H.; Gao, E. Z.; Liu, X. N.; Sun, L. J.; Li, H. L.; Wang, P.; Zhao, Y. L.; Yu, Z. G. Hepatoprotective Effect of Active Constituents Isolated from Mung Beans (Phaseolus Radiatus L.) in an Alcohol-Induced Liver Injury Mouse Model. J. Food Biochem. 2014, 38(5), 453–459. DOI: 10.1111/jfbc.12083.
   Web of Science ®Google Scholar
• Elsayed, H. E.; Ebrahim, H. Y.; Mady, M. S.; Khattab, M. A.; El-Sayed, E. K.; Moharram, F. A. Ethnopharmacological Impact of Melaleuca Rugulosa (Link) Craven Leaves Extract on Liver Inflammation. J. Ethnopharmacol. 2022, 292, 115215. DOI: 10.1016/j.jep.2022.115215.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Chen, D.; Tu, Y.; Sang, T.; Pan, T.; Lin, H.; Cai, C.; Jin, X.; Wu, F.; Xu, L., et al. Vitexin Attenuates Autoimmune Hepatitis in Mouse Induced by Syngeneic Liver Cytosolic Proteins via Activation of AMPK/AKT/GSK-3β/Nrf2 Pathway. Eur. J. Pharmacol. 2022, 917, 174720. DOI: 10.1016/j.ejphar.2021.174720.
   PubMed Web of Science ®Google Scholar
• Duan, S.; Du, X.; Chen, S.; Liang, J.; Huang, S.; Hou, S.; Gao, J.; Ding, P. Effect of Vitexin on Alleviating Liver Inflammation in a Dextran Sulfate Sodium (DSS)-Induced Colitis Model. Biomed. Pharmacother. 2020, 121, 109683. DOI: 10.1016/j.biopha.2019.109683.
   PubMed Web of Science ®Google Scholar
• Sharma, P.; Bodhankar, S. L.; Thakurdesai, P. A. Protective Effect of Aqueous Extract of Feronia Elephantum Correa Leaves on Thioacetamide Induced Liver Necrosis in Diabetic Rats. Asian Pac. J. Trop. Biomed. 2012, 2(9), 691–695. DOI: 10.1016/s2221-1691(12)60211-1.
   PubMedGoogle Scholar
• He, J.; Yang, R. Effects of Propofol and Vitexin on Apoptosis in Rat Liver Ischemia Reperfusion Injury. Pakistan J. Zool. 2022, 54(3), 1463–1466. DOI: 10.17582/journal.pjz/20200321080348.
   Web of Science ®Google Scholar
• Sahreen, S.; Khan, M. R.; Khan, R. A. Hepatoprotective Effects of Methanol Extract of Carissa Opaca Leaves on CCl4-Induced Damage in Rat. BMC Complement. Altern. Med. 2011, 11(1), 48. DOI: 10.1186/1472-6882-11-48.
   PubMedGoogle Scholar
• Lunardi, R. F.; Wohlenberg, M.; Medeiros, N.; Agostini, F.; Funchal, C.; Dani, C. In vitro Antioxidant Capacity of Tea of Echinodorus Grandiforus, “Leather hat,” in Wistar Rat Liver. An. Acad. Bras. Cienc. 2014, 86(3), 1451–1462. DOI: 10.1590/0001-3765201420130507.
   PubMed Web of Science ®Google Scholar
• Zhang, C.; Li, S.; Sun, C.; Liu, L.; Fang, Y.; Yang, X.; Pan, X.; Zhang, B. Vitexin Ameliorates Glycochenodeoxycholate-Induced Hepatocyte Injury Through SIRT6 and JAK2/STAT3 Pathways. Iran J. Basic Med. Sci. 2021, 24(12), 1717–1725. DOI: 10.22038/ijbms.2021.59424.13196.
   PubMed Web of Science ®Google Scholar
• Shi, Y. Y.; Deng, L. D.; Rao, W. W.; Xu, Q. 牡荆素对人肝细胞癌SMMC-7721细胞的增殖抑制作用及其机制的影响. Chin. J. Hosp. Pharm. 2016, 36(5), 366–371.
   Google Scholar
• Bedogni, G.; Miglioli, L.; Masutti, F.; Tiribelli, C.; Marchesini, G.; Bellentani, S. Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study. Hepatology. 2005, 42(1), 44–52. DOI: 10.1002/hep.20734.
   PubMed Web of Science ®Google Scholar
• Younossi, Z.; Anstee, Q. M.; Marietti, M.; Hardy, T.; Henry, L.; Eslam, M.; George, J.; Bugianesi, E. Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology. 2018, 15(1), 11–20. DOI: 10.1038/nrgastro.2017.109.
   PubMed Web of Science ®Google Scholar
• Kotronen, A.; Yki-Järvinen, H. Fatty Liver: A Novel Component of the Metabolic Syndrome. Arterioscler Thromb. Vasc. Biol. 2008, 28(1), 27–38. DOI: 10.1161/atvbaha.107.147538.
   PubMed Web of Science ®Google Scholar
• Eslam, M.; Newsome, P. N.; Sarin, S. K.; Anstee, Q. M.; Targher, G.; Romero-Gomez, M.; Zelber-Sagi, S.; Wai-Sun Wong, V.; Dufour, J. F.; Schattenberg, J. M., et al. A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement. J. Hepatol. 2020, 73 (1), 202–209. DOI: 10.1016/j.jhep.2020.03.039.
   PubMed Web of Science ®Google Scholar
• Fouad, Y.; Waked, I.; Bollipo, S.; Gomaa, A.; Ajlouni, Y.; Attia, D. What’s in a Name? Renaming ‘NAFLD’ to ‘MAFLD’. Liver Int. 2020, 40(6), 1254–1261. DOI: 10.1111/liv.14478.
   PubMed Web of Science ®Google Scholar
• Powell, E. E.; Wong, V. W.; Rinella, M. Non-Alcoholic Fatty Liver Disease. Lancet. 2021, 397(10290), 2212–2224. DOI: 10.1016/s0140-6736(20)32511-3.
   PubMed Web of Science ®Google Scholar
• Serfaty, L.; Lemoine, M. Definition and Natural History of Metabolic Steatosis: Clinical Aspects of NAFLD, NASH and Cirrhosis. Diabetes Metab. 2008, 34(6), 634–637. DOI: 10.1016/s1262-3636(08)74597-x.
   PubMed Web of Science ®Google Scholar
• Gerges, S. H.; Wahdan, S. A.; Elsherbiny, D. A.; El-Demerdash, E. Non-Alcoholic Fatty Liver Disease: An Overview of Risk Factors, Pathophysiological Mechanisms, Diagnostic Procedures, and Therapeutic Interventions. Life. sci. 2021, 271, 119220. DOI: 10.1016/j.lfs.2021.119220.
   PubMed Web of Science ®Google Scholar
• Esler, W. P.; Bence, K. K. Metabolic Targets in Nonalcoholic Fatty Liver Disease. Cell. Mol. Gastroenterol. Hepatol. 2019, 8(2), 247–267. DOI: 10.1016/j.jcmgh.2019.04.007.
   PubMed Web of Science ®Google Scholar
• Manne, V.; Handa, P.; Kowdley, K. V. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clin. Liver Dis. 2018, 22(1), 23–37. DOI: 10.1016/j.cld.2017.08.007.
   PubMed Web of Science ®Google Scholar
• Buzzetti, E.; Pinzani, M.; Tsochatzis, E. A. The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism. 2016, 65(8), 1038–1048. DOI: 10.1016/j.metabol.2015.12.012.
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri, B. A. Non-Alcoholic Fatty Liver Disease. BMC Med. 2017, 15(1), 45. DOI: 10.1186/s12916-017-0806-8.
   PubMed Web of Science ®Google Scholar
• Paternostro, R.; Trauner, M. Current Treatment of Non-Alcoholic Fatty Liver Disease. J. Intern. Med. 2022, 292(2), 190–204. DOI: 10.1111/joim.13531.
   PubMed Web of Science ®Google Scholar
• Yan, M. X.; Chen, Z. Y.; He, B. H. 山楂叶总黄酮对非酒精性脂肪性肝炎大鼠肝组织NF-κB及其抑制物表达的影响. China J. Tradit. Chin. Med. And Pharm. 2009, 2, 139–143.
   Google Scholar
• Wang, S.; Kaufman, R. J. How Does Protein Misfolding in the Endoplasmic Reticulum Affect Lipid Metabolism in the Liver? Curr. Opin. Lipidol. 2014, 25(2), 125–132. DOI: 10.1097/mol.0000000000000056.
   PubMed Web of Science ®Google Scholar
• Ipsen, D. H.; Lykkesfeldt, J.; Tveden-Nyborg, P. Molecular Mechanisms of Hepatic Lipid Accumulation in Non-Alcoholic Fatty Liver Disease. Cell. Mol. Life Sci. 2018, 75(18), 3313–3327. DOI: 10.1007/s00018-018-2860-6.
   PubMed Web of Science ®Google Scholar
• Stern, J. H.; Rutkowski, J. M.; Scherer, P. E. Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis Through Adipose Tissue Crosstalk. Cell Metab. 2016, 23(5), 770–784. DOI: 10.1016/j.cmet.2016.04.011.
   PubMed Web of Science ®Google Scholar
• Friedman, S. L.; Neuschwander-Tetri, B. A.; Rinella, M.; Sanyal, A. J. Mechanisms of NAFLD Development and Therapeutic Strategies. Nat. Med. 2018, 24(7), 908–922. DOI: 10.1038/s41591-018-0104-9.
   PubMed Web of Science ®Google Scholar
• Takaki, A.; Kawai, D.; Yamamoto, K. Multiple Hits, Including Oxidative Stress, As Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH). Int. J. Mol. Sci. 2013, 14(10), 20704–20728. DOI: 10.3390/ijms141020704.
   PubMed Web of Science ®Google Scholar
• Yang, J.; Fernández-Galilea, M.; Martínez-Fernández, L.; González-Muniesa, P.; Pérez-Chávez, A.; Martínez, J. A.; Moreno-Aliaga, M. J. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. Nutr. 2019, 11(4), 872. DOI: 10.3390/nu11040872.
   Google Scholar
• Caldwell, S. H.; Swerdlow, R. H.; Khan, E. M.; Iezzoni, J. C.; Hespenheide, E. E.; Parks, J. K.; Parker, W. D., Jr. Mitochondrial Abnormalities in Non-Alcoholic Steatohepatitis. J. Hepatol. 1999, 31(3), 430–434. DOI: 10.1016/s0168-8278(99)80033-6.
   PubMed Web of Science ®Google Scholar
• Nassir, F.; Ibdah, J. A. Role of Mitochondria in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2014, 15(5), 8713–8742. DOI: 10.3390/ijms15058713.
   PubMed Web of Science ®Google Scholar
• Videla, L. A.; Rodrigo, R.; Orellana, M.; Fernandez, V.; Tapia, G.; Quiñones, L.; Varela, N.; Contreras, J.; Lazarte, R.; Csendes, A., et al. Oxidative Stress-Related Parameters in the Liver of Non-Alcoholic Fatty Liver Disease Patients. Clin Sci. (Lond). 2004, 106 (3), 261–268. DOI: 10.1042/cs20030285.
   PubMed Web of Science ®Google Scholar
• Park, M. H.; Kim, D. H.; Kim, M. J.; Lee, E. K.; An, H. J.; Jeong, J. W.; Kim, H. R.; Kim, S. J.; Yu, B. P.; Moon, H. R., et al. Effects of MHY908, a New Synthetic PPARα/γ Dual Agonist, on Inflammatory Responses and Insulin Resistance in Aged Rats. J Gerontol A Biol Sci Med Sci. 2016, 71(3), 300–309.
   PubMed Web of Science ®Google Scholar
• Zorov, D. B.; Juhaszova, M.; Sollott, S. J. Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release. Physiol. Rev. 2014, 94(3), 909–950. DOI: 10.1152/physrev.00026.2013.
   PubMed Web of Science ®Google Scholar
• Chandel, N. S. Evolution of Mitochondria As Signaling Organelles. Cell Metab. 2015, 22(2), 204–206. DOI: 10.1016/j.cmet.2015.05.013.
   PubMed Web of Science ®Google Scholar
• Hotamisligil, G. S. Inflammation and Metabolic Disorders. Nature. 2006, 444(7121), 860–867. DOI: 10.1038/nature05485.
   PubMed Web of Science ®Google Scholar
• Roh, Y. S.; Seki, E. Toll-Like Receptors in Alcoholic Liver Disease, Non-Alcoholic Steatohepatitis and Carcinogenesis. J. Gastroenterol. Hepatol. 2013, Suppl 28(S1), 38–42. DOI: 10.1111/jgh.12019.
   Google Scholar
• Wen, Y.; Lambrecht, J.; Ju, C.; Tacke, F. Hepatic Macrophages in Liver Homeostasis and Diseases-Diversity, Plasticity and Therapeutic Opportunities. Cell. Mol. Immunol. 2021, 18(1), 45–56. DOI: 10.1038/s41423-020-00558-8.
   PubMed Web of Science ®Google Scholar
• Cobbina, E.; Akhlaghi, F. Non-Alcoholic Fatty Liver Disease (NAFLD) - Pathogenesis, Classification, and Effect on Drug Metabolizing Enzymes and Transporters. Drug Metab. Rev. 2017, 49(2), 197–211. DOI: 10.1080/03602532.2017.1293683.
   PubMed Web of Science ®Google Scholar
• Xu, X.; Poulsen, K. L.; Wu, L.; Liu, S.; Miyata, T.; Song, Q.; Wei, Q.; Zhao, C.; Lin, C.; Yang, J. Targeted Therapeutics and Novel Signaling Pathways in Non-Alcohol-Associated Fatty Liver/Steatohepatitis (NAFL/NASH). Signal Transduct. Target. Ther. 2022, 7(1), 287. DOI: 10.1038/s41392-022-01119-3.
   PubMed Web of Science ®Google Scholar
• Luci, C.; Bourinet, M.; Leclère, P. S.; Anty, R.; Gual, P. Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies. Front. Endocrinol. (Lausanne). 2020, 11, 597648. DOI: 10.3389/fendo.2020.597648.
   PubMed Web of Science ®Google Scholar
• Peverill, W.; Powell, L. W.; Skoien, R. Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation. Int. J. Mol. Sci. 2014, 15(5), 8591–8638. DOI: 10.3390/ijms15058591.
   PubMed Web of Science ®Google Scholar
• Zhang, C. H.; Zhou, B. G.; Sheng, J. Q.; Chen, Y.; Cao, Y. Q.; Chen, C. Molecular Mechanisms of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease and Potential Treatment Strategies. Pharmacol. Res. 2020, 159, 104984. DOI: 10.1016/j.phrs.2020.104984.
   PubMed Web of Science ®Google Scholar
• Hwang, K. A.; Hwang, Y. J.; Kim, G. R.; Choe, J. S. Extracts from Aralia Elata (Miq) Seem Alleviate Hepatosteatosis via Improving Hepatic Insulin Sensitivity. BMC Complement. Altern. Med. 2015, 15(1), 347. DOI: 10.1186/s12906-015-0871-5.
   PubMedGoogle Scholar
• Roberts, C. K.; Hevener, A. L.; Barnard, R. J. Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training. Compr. Physiol. 2013, 3(1), 1–58. DOI: 10.1002/cphy.c110062.
   PubMed Web of Science ®Google Scholar
• Smith, U.; Axelsen, M.; Carvalho, E.; Eliasson, B.; Jansson, P. A.; Wesslau, C. Insulin Signaling and Action in Fat Cells: Associations with Insulin Resistance and Type 2 Diabetes. Ann. N Y Acad. Sci. 1999, 892(1), 119–126. DOI: 10.1111/j.1749-6632.1999.tb07790.x.
   PubMedGoogle Scholar
• Petersen, K. F.; Shulman, G. I. Etiology of Insulin Resistance. Am. j. med. 2006, 119(Suppl 5), S10–6. DOI: 10.1016/j.amjmed.2006.01.009.
   PubMed Web of Science ®Google Scholar
• Seitz, H. K.; Bataller, R.; Cortez-Pinto, H.; Gao, B.; Gual, A.; Lackner, C.; Mathurin, P.; Mueller, S.; Szabo, G.; Tsukamoto, H. Alcoholic Liver Disease. Nat. Rev. Dis. Primers. 2018, 4(1), 16. DOI: 10.1038/s41572-018-0014-7.
   PubMed Web of Science ®Google Scholar
• Sherlock, S. Alcoholic Liver Disease. Lancet. 1995, 345(8944), 227–229. DOI: 10.1016/s0140-6736(95)90226-0.
   PubMed Web of Science ®Google Scholar
• Louvet, A.; Mathurin, P. Alcoholic Liver Disease: Mechanisms of Injury and Targeted Treatment. Nature Reviews Gastroenterology & Hepatology. 2015, 12(4), 231–242. DOI: 10.1038/nrgastro.2015.35.
   PubMed Web of Science ®Google Scholar
• Ko, S.; Russell, J. O.; Molina, L. M.; Monga, S. P. Liver Progenitors and Adult Cell Plasticity in Hepatic Injury and Repair: Knowns and Unknowns. Annu. Rev. Pathol. 2020, 15(1), 23–50. DOI: 10.1146/annurev-pathmechdis-012419-032824.
   PubMedGoogle Scholar
• Stravitz, R. T.; Lee, W. M. Acute Liver Failure. Lancet. 2019, 394(10201), 869–881. DOI: 10.1016/s0140-6736(19)31894-x.
   PubMed Web of Science ®Google Scholar
• Hoppmann, N. A.; Gray, M. E.; McGuire, B. M. Drug-Induced Liver Injury in the Setting of Chronic Liver Disease. Clin. Liver Dis. 2020, 24(1), 89–106. DOI: 10.1016/j.cld.2019.09.006.
   PubMed Web of Science ®Google Scholar
• Li, X.; Tang, J.; Mao, Y. Incidence and Risk Factors of Drug-Induced Liver Injury. Liver Int. 2022, 42(9), 1999–2014. DOI: 10.1111/liv.15262.
   PubMed Web of Science ®Google Scholar
• Hoofnagle, J. H.; Björnsson, E. S. Drug-Induced Liver Injury - Types and Phenotypes. N. Engl. J. Med. 2019, 381(3), 264–273. DOI: 10.1056/NEJMra1816149.
   PubMed Web of Science ®Google Scholar
• Garcia-Cortes, M.; Robles-Diaz, M.; Stephens, C.; Ortega-Alonso, A.; Lucena, M. I.; Andrade, R. J. Drug Induced Liver Injury: An Update. Arch. Toxicol. 2020, 94(10), 3381–3407. DOI: 10.1007/s00204-020-02885-1.
   PubMed Web of Science ®Google Scholar
• Abboud, G.; Kaplowitz, N. Drug-Induced Liver Injury. Drug Saf. 2007, 30(4), 277–294. DOI: 10.2165/00002018-200730040-00001.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H. Pathophysiology of Hepatic Ischemia-Reperfusion Injury: The Role of Complement Activation. Gastroenterol. 1994, 107(2), 583–586. DOI: 10.1016/0016-5085(94)90188-0.
   PubMed Web of Science ®Google Scholar
• Basu, S. Carbon Tetrachloride-Induced Lipid Peroxidation: Eicosanoid Formation and Their Regulation by Antioxidant Nutrients. Toxicology. 2003, 189(1–2), 113–127. DOI: 10.1016/s0300-483x(03)00157-4.
   PubMed Web of Science ®Google Scholar
• Mihailovic, V.; Misic, D.; Matic, S.; Mihailovic, M.; Stanic, S.; Vrvic, M. M.; Katanic, J.; Mladenovic, M.; Stankovic, N.; Boroja, T., et al. Comparative Phytochemical Analysis of Gentiana Cruciata L. Roots and Aerial Parts, and Their Biological Activities. Ind. Crops Prod. 2015. 73, 49–62. DOI: 10.1016/j.indcrop.2015.04.013.
   Web of Science ®Google Scholar
• Lin, T. L.; Shu, C. C.; Chen, Y. M.; Lu, J. J.; Wu, T. S.; Lai, W. F.; Tzeng, C. M.; Lai, H. C.; Lu, C. C. Like Cures Like: Pharmacological Activity of Anti-Inflammatory Lipopolysaccharides from Gut Microbiome. Front. Pharmacol. 2020, 11, 554. DOI: 10.3389/fphar.2020.00554.
   PubMed Web of Science ®Google Scholar
• Schiessel, C.; Forsthove, C.; Keppler, D. 45Calcium Uptake During the Transition from Reversible to Irreversible Liver Injury Induced by D-Galactosamine in vivo. Hepatology. 1984, 4(5), 855–861. DOI: 10.1002/hep.1840040510.
   PubMed Web of Science ®Google Scholar
• Banskota, A. H.; Tezuka, Y.; Adnyana, I. K.; Xiong, Q.; Hase, K.; Tran, K. Q.; Tanaka, K.; Saiki, I.; Kadota, S. Hepatoprotective Effect of Combretum Quadrangulare and Its Constituents. Biol. Pharm. Bull. 2000, 23(4), 456–460. DOI: 10.1248/bpb.23.456.
   PubMed Web of Science ®Google Scholar
• Wu, M. M.; Wang, C. L.; Mai, C. T.; Chen, J. N.; Lai, X. P.; He, L.; Huang, S.; Zhang, X. J. Flavonoids from Livistona Chinensis Fruit Ameliorates Lps/D-GalN-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Inflammation. J. Funct. Foods. 2019, 61, 61. DOI: 10.1016/j.jff.2019.103460.
   Web of Science ®Google Scholar
• Smith, R. P.; Wilcox, D. E. Toxicology of Selected Nitric Oxide-Donating Xenobiotics, with Particular Reference to Azide. Crit. Rev. Toxicol. 1994, 24(4), 355–377. DOI: 10.3109/10408449409017923.
   PubMed Web of Science ®Google Scholar
• Singh, C.; Prakash, C.; Mishra, P.; Tiwari, K. N.; Mishra, S. K.; More, R. S.; Kumar, V.; Singh, J. Hepatoprotective Efficacy of Premna Integrifolia L. Leaves Against Aflatoxin B1-Induced Toxicity in Mice. Toxicon. 2019, 166, 88–100. DOI: 10.1016/j.toxicon.2019.05.014.
   PubMed Web of Science ®Google Scholar
• Alcolado, R.; Arthur, M. J.; Iredale, J. P. Pathogenesis of Liver Fibrosis. Clin Sci. (Lond). 1997, 92(2), 103–112. DOI: 10.1042/cs0920103.
   PubMed Web of Science ®Google Scholar
• Friedman, S. L. Liver Fibrosis – from Bench to Bedside. J. Hepatol. 2003, 38(Suppl 1), S38–53. DOI: 10.1016/s0168-8278(02)00429-4.
   PubMed Web of Science ®Google Scholar
• Heymann, F.; Tacke, F. Immunology in the Liver–From Homeostasis to Disease. Nature Reviews Gastroenterology & Hepatology. 2016, 13(2), 88–110. DOI: 10.1038/nrgastro.2015.200.
   PubMed Web of Science ®Google Scholar
• Friedman, S. L. Mechanisms of Hepatic Fibrogenesis. Gastroenterol. 2008, 134(6), 1655–1669. DOI: 10.1053/j.gastro.2008.03.003.
   PubMed Web of Science ®Google Scholar
• Köhler, U. A.; Böhm, F.; Rolfs, F.; Egger, M.; Hornemann, T.; Pasparakis, M.; Weber, A.; Werner, S. NF-κB/RelA and Nrf2 Cooperate to Maintain Hepatocyte Integrity and to Prevent Development of Hepatocellular Adenoma. J. Hepatol. 2016, 64(1), 94–102. DOI: 10.1016/j.jhep.2015.08.033.
   PubMed Web of Science ®Google Scholar
• Papanikolaou, I. G.; Katselis, C.; Apostolou, K.; Feretis, T.; Lymperi, M.; Konstadoulakis, M. M.; Papalois, A. E.; Zografos, G. C. Mesenchymal Stem Cells Transplantation Following Partial Hepatectomy: A New Concept to Promote Liver Regeneration-Systematic Review of the Literature Focused on Experimental Studies in Rodent Models. Stem Cells Int. 2017, 2017, 7567958. DOI: 10.1155/2017/7567958.
   PubMed Web of Science ®Google Scholar
• Hirschfield, G. M.; Heathcote, E. J.; Gershwin, M. E. Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches. Gastroenterol. 2010, 139(5), 1481–1496. DOI: 10.1053/j.gastro.2010.09.004.
   PubMed Web of Science ®Google Scholar
• Gossard, A. A.; Talwalkar, J. A. Cholestatic Liver Disease. Med. Clin. North Am. 2014, 98(1), 73–85. DOI: 10.1016/j.mcna.2013.09.002.
   PubMed Web of Science ®Google Scholar
• Yokoda, R. T.; Carey, E. J. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Am. J. Gastroenterol. 2019, 114(10), 1593–1605. DOI: 10.14309/ajg.0000000000000268.
   PubMed Web of Science ®Google Scholar
• Pasha, T. M.; Lindor, K. D. Diagnosis and Therapy of Cholestatic Liver Disease. Med. Clin. North Am. 1996, 80(5), 995–1019. DOI: 10.1016/s0025-7125(05)70477-6.
   PubMed Web of Science ®Google Scholar
• Wei, C.; Qiu, J.; Wu, Y.; Chen, Z.; Yu, Z.; Huang, Z.; Yang, K.; Hu, H.; Liu, F. Promising Traditional Chinese Medicine for the Treatment of Cholestatic Liver Disease Process (Cholestasis, Hepatitis, Liver Fibrosis, Liver Cirrhosis). J. Ethnopharmacol. 2022, 297, 115550. DOI: 10.1016/j.jep.2022.115550.
   PubMed Web of Science ®Google Scholar
• Goldstein, J.; Levy, C. Novel and Emerging Therapies for Cholestatic Liver Diseases. Liver Int. 2018, 38(9), 1520–1535. DOI: 10.1111/liv.13880.
   PubMed Web of Science ®Google Scholar
• Wagner, M.; Fickert, P. Drug Therapies for Chronic Cholestatic Liver Diseases. Annu. Rev. Pharmacol. Toxicol. 2020, 60(1), 503–527. DOI: 10.1146/annurev-pharmtox-010818-021059.
   PubMedGoogle Scholar
• El-Serag, H. B.; Rudolph, K. L. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterol. 2007, 132(7), 2557–2576. DOI: 10.1053/j.gastro.2007.04.061.
   PubMed Web of Science ®Google Scholar
• Petrick, J. L.; Braunlin, M.; Laversanne, M.; Valery, P. C.; Bray, F.; McGlynn, K. A. International Trends in Liver Cancer Incidence, Overall and by Histologic Subtype, 1978-2007. Int, J, Cancer. 2016, 139(7), 1534–1545. DOI: 10.1002/ijc.30211.
   PubMed Web of Science ®Google Scholar
• Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68(6), 394–424. DOI: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71(3), 209–249. DOI: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Perz, J. F.; Armstrong, G. L.; Farrington, L. A.; Hutin, Y. J.; Bell, B. P. The Contributions of Hepatitis B Virus and Hepatitis C Virus Infections to Cirrhosis and Primary Liver Cancer Worldwide. J. Hepatol. 2006, 45(4), 529–538. DOI: 10.1016/j.jhep.2006.05.013.
   PubMed Web of Science ®Google Scholar
• Stuver, S. O. Towards Global Control of Liver Cancer? Semin. Cancer Biol. 1998, 8(4), 299–306. DOI: 10.1006/scbi.1998.0079.
   PubMed Web of Science ®Google Scholar
• Hussain, S. A.; Ferry, D. R.; El-Gazzaz, G.; Mirza, D. F.; James, N. D.; McMaster, P.; Kerr, D. J. Hepatocellular Carcinoma. Ann. Oncol. 2001, 12(2), 161–172. DOI: 10.1023/a:1008370324827.
   PubMed Web of Science ®Google Scholar
• Aravalli, R. N.; Cressman, E. N.; Steer, C. J. Cellular and Molecular Mechanisms of Hepatocellular Carcinoma: An Update. Arch. Toxicol. 2013, 87(2), 227–247. DOI: 10.1007/s00204-012-0931-2.
   PubMed Web of Science ®Google Scholar
• Forner, A.; Reig, M.; Bruix, J. Hepatocellular Carcinoma. Lancet. 2018, 391(10127), 1301–1314. DOI: 10.1016/s0140-6736(18)30010-2.
   PubMed Web of Science ®Google Scholar
• Villanueva, A.; Longo, D. L. Hepatocellular Carcinoma. N. Engl. J. Med. 2019, 380(15), 1450–1462. DOI: 10.1056/NEJMra1713263.
   PubMed Web of Science ®Google Scholar
• Anwanwan, D.; Singh, S. K.; Singh, S.; Saikam, V.; Singh, R. Challenges in Liver Cancer and Possible Treatment Approaches. Biochim. Biophys. Acta. Rev. Cancer. 2020, 1873(1), 188314. DOI: 10.1016/j.bbcan.2019.188314.
   PubMed Web of Science ®Google Scholar
• Liang, C.; Jiang, Y.; Sun, L. Vitexin Suppresses the Proliferation, Angiogenesis and Stemness of Endometrial Cancer Through the PI3K/AKT Pathway. Pharm. Biol. 2023, 61(1), 581–589. DOI: 10.1080/13880209.2023.2190774.
   PubMed Web of Science ®Google Scholar
• Chen, Y.; Wang, B.; Yuan, X.; Lu, Y.; Hu, J.; Gao, J.; Lin, J.; Liang, J.; Hou, S.; Chen, S. Vitexin Prevents Colitis-Associated Carcinogenesis in Mice Through Regulating Macrophage Polarization. Phytomedicine. 2021, 83, 153489. DOI: 10.1016/j.phymed.2021.153489.
   PubMed Web of Science ®Google Scholar
• Sousa AP, F. M.; Fernandes, D. A.; Fernandes, D. A.; Cordeiro, L. V.; Souza, M. D. F. V. D.; Pessoa, H. D. L. F.; Oliveira, A. A. D.; Sá, R. D. C. D. S. E. In Silico, in vitro and ex-Vivo Toxicological Profiling of 5,7,4’-Trihydroxyflavone-8 -C-ß-Glucopyranoside - Vitexin. Rev. Ciênc. Farm Básica. Apl. 2021, 42(42), e709. DOI: 10.4322/2179-443X.0709.
   Google Scholar
• Choo, C. Y.; Sulong, N. Y.; Man, F.; Wong, T. W. Vitexin and Isovitexin from the Leaves of Ficus Deltoidea with in-Vivo α-Glucosidase Inhibition. J. Ethnopharmacol. 2012, 142(3), 776–781. DOI: 10.1016/j.jep.2012.05.062.
   PubMed Web of Science ®Google Scholar
• Li, X. L.; Shao, X.; Niu, H. J.; Xu, L.; Li, G. H. Beagle犬牡荆素急性毒性实验研究. J. Clin. Ration. Drug Use. 2017, 10(22), 56–57.
   Google Scholar
• Niu, H. J.; Li, X. L.; Li, G. H. 注射用牡荆素Beagle犬长期毒性试验研究. China Pharm. 2019, 28(12), 4–10.
   Google Scholar
• Rosa, S. I.; Rios-Santos, F.; Balogun, S. O.; Martins, D. T. Vitexin Reduces Neutrophil Migration to Inflammatory Focus by Down-Regulating Pro-Inflammatory Mediators via Inhibition of p38, ERK1/2 and JNK Pathway. Phytomedicine. 2016, 23(1), 9–17. DOI: 10.1016/j.phymed.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Pires, V. A.; Cardozo-Junior, E. L.; Ortmann, C. F.; Maraschin, J. C.; Favreto, W. A. J.; Donaduzzi, C. M.; Reginatto, F. H.; Assreuy, J. Lipid-Lowering and Antiatherogenic Effects of Vitex Megapotamica (Spreng.) Moldenke in a Mice Experimental Model. J. Ethnopharmacol. 2018, 215, 14–20. DOI: 10.1016/j.jep.2017.12.030.
   PubMed Web of Science ®Google Scholar
• Hassan, I.; Wan Ibrahim, W. N.; Yusuf, F. M.; Ahmad, S. A.; Ahmad, S. Biochemical Constituent of Ginkgo Biloba (Seed) 80% Methanol Extract Inhibits Cholinesterase Enzymes in Javanese Medaka (Oryzias Javanicus) Model. J. Toxicol. 2020, 2020, 8815313. DOI: 10.1155/2020/8815313.
   PubMed Web of Science ®Google Scholar
• Kim, J.; Lee, I.; Seo, J.; Jung, M.; Kim, Y.; Yim, N.; Bae, K. Vitexin, Orientin and Other Flavonoids from Spirodela Polyrhiza Inhibit Adipogenesis in 3T3-L1 Cells. Phytother. Res. 2010, 24(10), 1543–1548. DOI: 10.1002/ptr.3186.
   PubMed Web of Science ®Google Scholar
• Farsi, E.; Shafaei, A.; Hor, S. Y.; Ahamed, M. B.; Yam, M. F.; Asmawi, M. Z.; Ismail, Z. Genotoxicity and Acute and Subchronic Toxicity Studies of a Standardized Methanolic Extract of Ficus Deltoidea Leaves. Clin. (Sao Paulo). 2013, 68(6), 865–875. DOI: 10.6061/clinics/2013(06)23.
   PubMed Web of Science ®Google Scholar
• Yang, S. H.; Liao, P. H.; Pan, Y. F.; Chen, S. L.; Chou, S. S.; Chou, M. Y. The Novel p53-Dependent Metastatic and Apoptotic Pathway Induced by Vitexin in Human Oral Cancer OC2 Cells. Phytother. Res. 2013, 27(8), 1154–1161. DOI: 10.1002/ptr.4841.
   PubMed Web of Science ®Google Scholar
• Ganesan, K.; Xu, B. Molecular Targets of Vitexin and Isovitexin in Cancer Therapy: A Critical Review. Ann. N Y Acad. Sci. 2017, 1401(1), 102–113. DOI: 10.1111/nyas.13446.
   PubMed Web of Science ®Google Scholar
• Chen, D.; Chen, Y.; Huang, F.; Zhang, X.; Zhou, Y.; Xu, L. The Underlying Regulatory Mechanisms of Colorectal Carcinoma by Combining Vitexin and Aspirin: Based on Systems Biology, Molecular Docking, Molecular Dynamics Simulation, and in vitro Study. Front. Endocrinol. (Lausanne). 2023, 14, 1147132. DOI: 10.3389/fendo.2023.1147132.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman, S. M.; Kauffman, R. E. The Integration of Pharmacokinetics and Pharmacodynamics: Understanding Dose-Response. Annu. Rev. Pharmacol. Toxicol. 2004, 44(1), 111–136. DOI: 10.1146/annurev.pharmtox.44.101802.121347.
   PubMedGoogle Scholar
• Fan, J.; de Lannoy, I. A. Pharmacokinetics. Biochem Pharmacol. 2014, 87(1), 93–120. DOI: 10.1016/j.bcp.2013.09.007.
   PubMed Web of Science ®Google Scholar
• Cui, S. M.; Wei, X. F.; Zhang, J.; Ye, Z. Z.; Liao, H. W. HPLC-MS/MS测定血浆中的牡荆素及其大鼠体内药动学研究. Zhong Yao Cai. 2012, 35(7), 1120–1123.
   PubMedGoogle Scholar
• Huang, Y.; He, F.; Zhang, Z. R.; Zheng, L.; Lan, Y. Y.; Wang, Y. L. HPLC-MS-MS同时检测大鼠血浆中荭草素、牡荆素和槲皮苷. Chin. J. Exp. Traditional Med. Formulae. 2012, 18(1), 80–84.
   Google Scholar
• Yan, C.; Liu, H.; Lin, L. Simultaneous Determination of Vitexin and Isovitexin in Rat Plasma After Oral Administration of Santalum Album L. Leaves Extract by Liquid Chromatography Tandem Mass Spectrometry. Biomed. Chromatogr. 2013, 27(2), 228–232. DOI: 10.1002/bmc.2780.
   PubMed Web of Science ®Google Scholar
• Zhang, S.; Xie, Y.; Wang, J.; Geng, Y.; Zhou, Y.; Sun, C.; Wang, G. Development of an LC-MS/MS Method for Quantification of Two Pairs of Isomeric Flavonoid Glycosides and Other Ones in Rat Plasma: Application to Pharmacokinetic Studies. Biomed. Chromatogr. 2017, 31(10). DOI: 10.1002/bmc.3972.
   Web of Science ®Google Scholar
• Luo, L.; Kang, J.; Zhao, W.; Qi, Y.; Liang, S. Validated LC-MS/MS Method for Simultaneous Quantification of Seven Components of Naodesheng in Rat Serum After Oral Administration and Its Application to a Pharmacokinetic Study. J. Pharm. Biomed. Anal. 2019, 174, 1–7. DOI: 10.1016/j.jpba.2019.05.036.
   PubMed Web of Science ®Google Scholar
• Bai, Y.; Zhang, Q.; Wang, B.; Zhang, M.; Xu, Y.; Li, S.; Zhao, Y.; Yu, Z. Plasma Pharmacokinetics, Bioavailability, and Tissue Distribution of Four C-Glycosyl Flavones from Mung Bean (Vigna Radiata L.) Seed Extracts in Rat by Ultrahigh-Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Agric. Food. Chem. 2017, 65(27), 5570–5580. DOI: 10.1021/acs.jafc.7b02053.
   PubMed Web of Science ®Google Scholar
• Zhu, S.; Yan, H.; Niu, K.; Zhang, S. Simultaneous Determination of Seven Components from Hawthorn Leaves Flavonoids in Rat Plasma by LC-MS/MS. J. Chromatogr. Sci. 2015, 53(6), 909–914. DOI: 10.1093/chromsci/bmu143.
   PubMed Web of Science ®Google Scholar
• Wang, S. Y.; Chai, J. Y.; Zhang, W. J.; Liu, X.; Du, Y.; Cheng, Z. Z.; Ying, X. X.; Kang, T. G. HPLC Determination of Five Polyphenols in Rat Plasma After Intravenous Administration of Hawthorn Leaves Extract and Its Application to Pharmacokinetic Study. Yakugaku Zasshi. 2010, 130(11), 1603–1613. DOI: 10.1248/yakushi.130.1603.
   PubMed Web of Science ®Google Scholar
• Wang, Y. J.; Qu, G. L.; Zhang, W. J.; Xue, H. F.; Chen, Y. H.; Yin, J. J.; Lu, D. R.; Ying, X. X. Pharmacokinetics Tissue Distribution and Excretion of Vitexin in Mice. Latin Am. J. Pharm. 2012, 31(6), 844–851.
   Web of Science ®Google Scholar
• Tan, D. P.; Li, G.; Lv, W. Y.; Shao, X.; Li, X. L.; Niu, H. J.; Xu, Y. Q.; Zhang, J. Y.; Qin, L.; He, Y. Q., et al. Distribution, Metabolism, Excretion and Toxicokinetics of Vitexin in Rats and Dogs. Curr. Pharm. Anal. 2022, 18(5), 553–564.
   Web of Science ®Google Scholar
• Zhang, W.; Xu, M.; Yu, C.; Zhang, G.; Tang, X. Simultaneous Determination of Vitexin-4’’-O-Glucoside, Vitexin-2’’-O-Rhamnoside, Rutin and Vitexin from Hawthorn Leaves Flavonoids in Rat Plasma by UPLC-ESI-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878(21), 1837–1844. DOI: 10.1016/j.jchromb.2010.05.023.
   PubMed Web of Science ®Google Scholar
• Sun, F.; Zeng, L.; Li, J.; Zhong, Y.; Wu, X.; Wang, K.; Wang, S.; Liang, S. Developing the Liquid Chromatography-Mass Spectrometry Method for Simultaneously Quantifying Five Components in Rat Serums After Oral Administration of Hawthorn Aqueous Extracts and Its Application to a Pharmacokinetic Study. J. Sep. Sci. 2022, 45(11), 1839–1846. DOI: 10.1002/jssc.202100906.
   PubMed Web of Science ®Google Scholar
• Li, D.; Wang, Q.; Xu, L.; Li, M.; Jing, X.; Zhang, L. Pharmacokinetic Study of Three Active Flavonoid Glycosides in Rat After Intravenous Administration of Trollius Ledebourii Extract by Liquid Chromatography. Biomed. Chromatogr. 2008, 22(10), 1130–1136. DOI: 10.1002/bmc.1035.
   PubMed Web of Science ®Google Scholar
• Lu, Y.; Li, N.; Lyu, T.; Wang, Y. L.; Pan, J.; Sun, J.; Li, Y. J.; Liu, C. H. UPLC-MS/MS研究荭草提取物的H9c2细胞药代动力学. Zhongguo Zhong Yao Za Zhi. 2021, 46(18), 4833–4840. DOI: 10.19540/j.cnki.cjcmm.20210618.202.
   PubMedGoogle Scholar
• Xue, H. F.; Ying, Z. M.; Zhang, W. J.; Meng, Y. H.; Ying, X. X.; Kang, T. G. Hepatic, Gastric, and Intestinal First-Pass Effects of Vitexin in Rats. Pharm. Biol. 2014, 52(8), 967–971. DOI: 10.3109/13880209.2013.874464.
   PubMed Web of Science ®Google Scholar
• Guo, L.; Qiao, S.; Hu, J.; Li, D.; Zheng, S.; Shi, D.; Liu, J.; Wang, R. Investigation of the Effective Components of the Flowers of Trollius Chinensis from the Perspectives of Intestinal Bacterial Transformation and Intestinal Absorption. Pharm. Biol. 2017, 55(1), 1747–1758. DOI: 10.1080/13880209.2017.1321023.
   PubMed Web of Science ®Google Scholar
• Liu, L.; Guo, L.; Zhao, C.; Wu, X.; Wang, R.; Liu, C.; Blachier, F. Characterization of the Intestinal Absorption of Seven Flavonoids from the Flowers of Trollius Chinensis Using the Caco-2 Cell Monolayer Model. PLoS One. 2015, 10(3), e0119263. DOI: 10.1371/journal.pone.0119263.
   PubMed Web of Science ®Google Scholar
• Yang, B.; Liu, H. L.; Yang, J. L.; Gupta, V. K.; Jiang, Y. M. New Insights on Bioactivities and Biosynthesis of Flavonoid Glycosides. Trends Food Sci. Technol. 2018, 79, 116–124. DOI: 10.1016/j.tifs.2018.07.006.
   Web of Science ®Google Scholar
• Adepu, S.; Ramakrishna, S. Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules. 2021, 26(19), 5905. DOI: 10.3390/molecules26195905.
   PubMed Web of Science ®Google Scholar
• Liu, C. H.; Wang, M. J.; Yang, S. T.; Li, N.; Lu, Y.; Pan, J.; Li, Y. J.; Wang, Y. L.; Sun, J. 基于外翻肠囊模型研究荭草提取物在正常和心肌缺血模型大鼠中的肠吸收特征. Zhongguo Zhong Yao Za Zhi. 2021, 46(1), 196–205. DOI: 10.19540/j.cnki.cjcmm.20201010.201.
   PubMedGoogle Scholar
• Zhang, S. X.; Xie, Y.; Wang, J.; Geng, Y. M.; Zhou, Y.; Sun, C. X.; Wang, G. S. Simultaneous Determination of Six Bioactive Components of Total Flavonoids of Scorzonera Austriaca in Rat Tissues by LC-MS/MS: Application to a Tissue Distribution Study. Rev. bras. de farmacogn.-Braz. Pharmacogn. 2018, 28(2), 156–164. DOI: 10.1016/j.bjp.2018.01.004.
   Google Scholar
• Tremmel, M.; Paetz, C.; Heilmann, J. In vitro Liver Metabolism of Six Flavonoid C-Glycosides. Molecules. 2021, 26(21), 6632. DOI: 10.3390/molecules26216632.
   PubMed Web of Science ®Google Scholar
• Liao, M.; Cheng, X.; Diao, X.; Sun, Y.; Zhang, L. Metabolites Identificaion of Two Bioactive Constituents in Trollius Ledebourii in Rats Using Ultra-High-Performance Liquid Chromatography Coupled to Quadrupole Time-Of-Flight Mass Spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2017, 1068-1069, 297–312. DOI: 10.1016/j.jchromb.2017.10.061.
   PubMed Web of Science ®Google Scholar
• Dong, P.; Shi, L.; Wang, S.; Jiang, S.; Li, H.; Dong, F.; Xu, J.; Dai, L.; Zhang, J. Rapid Profiling and Identification of Vitexin Metabolites in Rat Urine, Plasma and Faeces After Oral Administration Using a UHPLC-Q-Exactive Orbitrap Mass Spectrometer Coupled with Multiple Data-Mining Methods. Curr. Drug Metab. 2021, 22(3), 185–197. DOI: 10.2174/1389200221999210101232841.
   PubMed Web of Science ®Google Scholar
• Wang, X. S.; Hu, X. C.; Chen, G. L.; Yuan, X.; Yang, R. N.; Liang, S.; Ren, J.; Sun, J. C.; Kong, G. Q.; Gao, S. G., et al. Effects of Vitexin on the Pharmacokinetics and mRNA Expression of CYP Isozymes in Rats. Phytother. Res. 2015, 29 (3), 366–372. DOI: 10.1002/ptr.5260.
   PubMed Web of Science ®Google Scholar
• de Oliveira, N. K. S.; Almeida, M. R. S.; Pontes, F. M. M.; Barcelos, M. P.; Silva, G. M.; de Paula da Silva, C. H. T.; Cruz, R. A. S.; da Silva Hage-Melim, L. I. Molecular Docking, Physicochemical Properties, Pharmacokinetics and Toxicity of Flavonoids Present in Euterpe Oleracea Martius. Curr. Comput.-Aided Drug Des. 2021, 17(4), 589–617. DOI: 10.2174/1573409916666200619122803.
   PubMed Web of Science ®Google Scholar
• Shaedi, N.; Naharudin, I.; Choo, C. Y.; Wong, T. W. Design of Oral Intestinal-Specific Alginate-Vitexin Nanoparticulate System to Modulate Blood Glucose Level of Diabetic Rats. Carbohydr. Polym. 2021, 254, 117312. DOI: 10.1016/j.carbpol.2020.117312.
   PubMed Web of Science ®Google Scholar
• Li, S.; Lv, H.; Chen, Y.; Song, H.; Zhang, Y.; Wang, S.; Luo, L.; Guan, X. N-Trimethyl Chitosan Coated Targeting Nanoparticles Improve the Oral Bioavailability and Antioxidant Activity of Vitexin. Carbohydr. Polym. 2022, 286, 119273. DOI: 10.1016/j.carbpol.2022.119273.
   PubMed Web of Science ®Google Scholar
• Szejtli, J. Medicinal Applications of Cyclodextrins. Med. Res. Rev. 1994, 14(3), 353–386. DOI: 10.1002/med.2610140304.
   PubMed Web of Science ®Google Scholar
• Uekama, K.; Hirayama, F.; Irie, T. Cyclodextrin Drug Carrier Systems. Chem. Rev. 1998, 98(5), 2045–2076. DOI: 10.1021/cr970025p.
   PubMed Web of Science ®Google Scholar
• Costa, E. C.; Menezes, P. M. N.; de Almeida, R. L.; Silva, F. S.; de Araújo Ribeiro, L. A.; da Silva, J. A.; de Oliveira, A. P.; da Cruz Araújo, E. C.; Rolim, L. A.; Nunes, X. P. Inclusion of Vitexin in β-Cyclodextrin: Preparation, Characterization and Expectorant/Antitussive Activities. Heliyon. 2020, 6(12), e05461. DOI: 10.1016/j.heliyon.2020.e05461.
   PubMed Web of Science ®Google Scholar
• Singh, R.; Lillard, J. W., Jr. Nanoparticle-Based Targeted Drug Delivery. Exp. Mol. Pathol. 2009, 86(3), 215–223. DOI: 10.1016/j.yexmp.2008.12.004.
   PubMed Web of Science ®Google Scholar
• Gu, C.; Liu, Z.; Yuan, X.; Li, W.; Zu, Y.; Fu, Y. Preparation of Vitexin Nanoparticles by Combining the Antisolvent Precipitation and High Pressure Homogenization Approaches Followed by Lyophilization for Dissolution Rate Enhancement. Molecules. 2017, 22(11), 2038. DOI: 10.3390/molecules22112038.
   PubMed Web of Science ®Google Scholar
• Rovoli, M.; Gortzi, O.; Lalas, S.; Kontopidis, G. β-Lactoglobulin Improves liposome’s Encapsulation Properties for Vitamin E Delivery. J. Liposome Res. 2014, 24(1), 74–81. DOI: 10.3109/08982104.2013.839701.
   PubMed Web of Science ®Google Scholar
• Guimarães, D.; Cavaco-Paulo, A.; Nogueira, E. Design of Liposomes As Drug Delivery System for Therapeutic Applications. Int. J. Pharm. 2021, 601, 120571. DOI: 10.1016/j.ijpharm.2021.120571.
   PubMed Web of Science ®Google Scholar
• Farooq, A.; Iqbal, A.; Rana, N. F.; Fatima, M.; Maryam, T.; Batool, F.; Rehman, Z.; Menaa, F.; Azhar, S.; Nawaz, A., et al. A Novel Sprague-Dawley Rat Model Presents Improved NASH/NAFLD Symptoms with PEG Coated Vitexin Liposomes. Int. J. Mol. Sci. 2022, 23(6), 3131.
   PubMed Web of Science ®Google Scholar
• Klibanov, A. L.; Maruyama, K.; Torchilin, V. P.; Huang, L. Amphipathic Polyethyleneglycols Effectively Prolong the Circulation Time of Liposomes. FEBS Lett. 1990, 268(1), 235–237. DOI: 10.1016/0014-5793(90)81016-h.
   PubMed Web of Science ®Google Scholar
• Mura, P. Advantages of the Combined Use of Cyclodextrins and Nanocarriers in Drug Delivery: A Review. Int. J. Pharm. 2020, 579, 119181. DOI: 10.1016/j.ijpharm.2020.119181.
   PubMedGoogle Scholar
• Bergström, C. A. Computational Models to Predict Aqueous Drug Solubility, Permeability and Intestinal Absorption. Expert. Opin. Drug. Metab. Toxicol. 2005, 1(4), 613–627. DOI: 10.1517/17425255.1.4.613.
   PubMedGoogle Scholar
• Stenberg, P.; Bergström, C. A.; Luthman, K.; Artursson, P. Theoretical Predictions of Drug Absorption in Drug Discovery and Development. Clin. Pharmacokinet. 2002, 41(11), 877–899. DOI: 10.2165/00003088-200241110-00005.
   PubMed Web of Science ®Google Scholar
• Yamashita, F.; Hashida, M. Pharmacokinetic Considerations for Targeted Drug Delivery. Adv. Drug Deliv. Rev. 2013, 65(1), 139–147. DOI: 10.1016/j.addr.2012.11.006.
   PubMed Web of Science ®Google Scholar
• Yang, B.; Liu, H.; Yang, J.; Gupta, V. K.; Jiang, Y. New Insights on Bioactivities and Biosynthesis of Flavonoid Glycosides. Trends Food Sci. Technol. 2018, 79, 116–124. DOI: 10.1016/j.tifs.2018.07.006.
   Web of Science ®Google Scholar
• Huang, Y.; He, F.; Zhang, Z.-R.; Zheng, L.; Lan, Y.-Y.; Wang, Y.-L. Simultaneous Determination of Orientin，vitexin and Quercitrin in Rat Plasma by UPLC-MS-MS. Chin. J. Exp. Traditional Med. Formulae. 2012, 18(1), 80–84. DOI: 10.13422/j.cnki.syfjx.2012.01.033.
   Google Scholar
• Yin, J.; Qu, J.; Zhang, W.; Lu, D.; Gao, Y.; Ying, X.; Kang, T. Tissue Distribution Comparison Between Healthy and Fatty Liver Rats After Oral Administration of Hawthorn Leaf Extract. Biomed. Chromatogr. 2014, 28(5), 637–647. DOI: 10.1002/bmc.3082.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Tang, L.; Cao, X.; Zheng, L.; Wang, A. M.; Huang, Y. 荭草提取物的肠外翻吸收研究. Zhongguo Zhong Yao Za Zhi. 2014, 39(11), 2121–2125.
   PubMedGoogle Scholar
• Lu, Y.; Li, N.; Zhu, X.; Pan, J.; Wang, Y.; Lan, Y.; Li, Y.; Wang, A.; Sun, J.; Liu, C. Comparative Analysis of Excretion of Six Major Compounds of Polygonum Orientale L. Extract in Urine, Feces and Bile Under Physiological and Myocardial Ischemia Conditions in Rats Using UPLC-MS/MS. Biomed. Chromatogr. 2021, 35(10), e5174. DOI: 10.1002/bmc.5174.
   PubMed Web of Science ®Google Scholar
• Bhambhani, S.; Kondhare, K. R.; Giri, A. P. Diversity in Chemical Structures and Biological Properties of Plant Alkaloids. Molecules. 2021, 26(11), 3374. DOI: 10.3390/molecules26113374.
   PubMed Web of Science ®Google Scholar
• Isika, D. K.; Sadik, O. A. Selective Structural Derivatization of Flavonoid Acetamides Significantly Impacts Their Bioavailability and Antioxidant Properties. Molecules. 2022, 27(23), 8133. DOI: 10.3390/molecules27238133.
   PubMed Web of Science ®Google Scholar
• Wu, J. Y.; Wang, T. Y.; Ding, H. Y.; Zhang, Y. R.; Lin, S. Y.; Chang, T. S. Enzymatic Synthesis of Novel Vitexin Glucosides. Molecules. 2021, 26(20), 6274. DOI: 10.3390/molecules26206274.
   PubMed Web of Science ®Google Scholar